Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3105106rdf:typepubmed:Citationlld:pubmed
pubmed-article:3105106lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:3105106lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:3105106lifeskim:mentionsumls-concept:C0032143lld:lifeskim
pubmed-article:3105106lifeskim:mentionsumls-concept:C0443315lld:lifeskim
pubmed-article:3105106lifeskim:mentionsumls-concept:C0005508lld:lifeskim
pubmed-article:3105106lifeskim:mentionsumls-concept:C0021492lld:lifeskim
pubmed-article:3105106pubmed:issue3lld:pubmed
pubmed-article:3105106pubmed:dateCreated1987-5-6lld:pubmed
pubmed-article:3105106pubmed:abstractTextThe bioavailability of human recombinant tissue plasminogen activator (rt-PA) in rats was measured after subcutaneous (s.c.) and intramuscular (i.m.) injection. Rt-PA was absorbed after both i.m. and s.c. injection, giving peak plasma concentrations within 30 min and 1 h, respectively, with detectable concentrations up to 6 h. These peak values of bioavailable t-PA were obtained in a functional fibrin plate assay of euglobulin precipitates and expressed as +88% and +243% (for s.c. and i.m. routes respectively) above basal rat fibrinolytic activity. Prior injection of rt-PA, s.c. or i.m., significantly reduced the weights of thrombi induced in the inferior vena cava after injection.lld:pubmed
pubmed-article:3105106pubmed:languageenglld:pubmed
pubmed-article:3105106pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3105106pubmed:citationSubsetIMlld:pubmed
pubmed-article:3105106pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3105106pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3105106pubmed:statusMEDLINElld:pubmed
pubmed-article:3105106pubmed:monthDeclld:pubmed
pubmed-article:3105106pubmed:issn0340-6245lld:pubmed
pubmed-article:3105106pubmed:authorpubmed-author:GaffneyP JPJlld:pubmed
pubmed-article:3105106pubmed:authorpubmed-author:PooleSSlld:pubmed
pubmed-article:3105106pubmed:authorpubmed-author:HanleySSlld:pubmed
pubmed-article:3105106pubmed:authorpubmed-author:CreightonL...lld:pubmed
pubmed-article:3105106pubmed:authorpubmed-author:Garcia...lld:pubmed
pubmed-article:3105106pubmed:authorpubmed-author:CurtisA DADlld:pubmed
pubmed-article:3105106pubmed:issnTypePrintlld:pubmed
pubmed-article:3105106pubmed:day15lld:pubmed
pubmed-article:3105106pubmed:volume56lld:pubmed
pubmed-article:3105106pubmed:ownerNLMlld:pubmed
pubmed-article:3105106pubmed:authorsCompleteYlld:pubmed
pubmed-article:3105106pubmed:pagination299-301lld:pubmed
pubmed-article:3105106pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:3105106pubmed:meshHeadingpubmed-meshheading:3105106-...lld:pubmed
pubmed-article:3105106pubmed:meshHeadingpubmed-meshheading:3105106-...lld:pubmed
pubmed-article:3105106pubmed:meshHeadingpubmed-meshheading:3105106-...lld:pubmed
pubmed-article:3105106pubmed:meshHeadingpubmed-meshheading:3105106-...lld:pubmed
pubmed-article:3105106pubmed:meshHeadingpubmed-meshheading:3105106-...lld:pubmed
pubmed-article:3105106pubmed:meshHeadingpubmed-meshheading:3105106-...lld:pubmed
pubmed-article:3105106pubmed:meshHeadingpubmed-meshheading:3105106-...lld:pubmed
pubmed-article:3105106pubmed:meshHeadingpubmed-meshheading:3105106-...lld:pubmed
pubmed-article:3105106pubmed:meshHeadingpubmed-meshheading:3105106-...lld:pubmed
pubmed-article:3105106pubmed:meshHeadingpubmed-meshheading:3105106-...lld:pubmed
pubmed-article:3105106pubmed:meshHeadingpubmed-meshheading:3105106-...lld:pubmed
pubmed-article:3105106pubmed:meshHeadingpubmed-meshheading:3105106-...lld:pubmed
pubmed-article:3105106pubmed:year1986lld:pubmed
pubmed-article:3105106pubmed:articleTitleBioavailability in rats of human recombinant tissue plasminogen activator after subcutaneous and intramuscular injection.lld:pubmed
pubmed-article:3105106pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3105106lld:pubmed